Published in Ann Rheum Dis on May 08, 2017
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Tutorial in biostatistics: competing risks and multi-state models. Stat Med (2007) 10.61
Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med (2004) 7.62
Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA (2009) 3.90
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol (2008) 2.77
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis (2010) 2.39
[Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire]. Z Rheumatol (1997) 2.34
Association between incident cancer and subsequent stroke. Ann Neurol (2015) 2.13
Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum (2006) 1.95
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis (2003) 1.91
Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum (2008) 1.73
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart (2004) 1.69
Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis. Arthritis Res Ther (2012) 1.57
Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis. Rheumatology (Oxford) (2016) 1.47
Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases. Arthritis Rheumatol (2017) 1.40
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab. Ann Rheum Dis (2013) 1.20
Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics (2011) 1.16
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis (2016) 1.15
Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs. Am J Med (2013) 1.01
Characteristics of in-hospital onset ischemic stroke. Eur Neurol (2006) 0.98
Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study. Ann Rheum Dis (2011) 0.95
The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis (2014) 0.94
Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis. Ann Rheum Dis (2012) 0.94
Stroke in hospitalized patients: are there special risk factors? Cerebrovasc Dis (2002) 0.88
Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Ann Rheum Dis (2015) 0.87
Infection, its treatment and the risk for stroke. Curr Vasc Pharmacol (2009) 0.85
Cerebrovascular Disease in Rheumatic Diseases: A Systematic Review and Meta-Analysis. Stroke (2016) 0.84
Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis. Arthritis Res Ther (2016) 0.81
Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis. Arthritis Rheumatol (2016) 0.78
Primary and secondary patient data in contrast: the use of observational studies like RABBIT. Clin Exp Rheumatol (2016) 0.77
Drug prescribing trends in adults with rheumatoid arthritis: a population-based comparative study from 2005 to 2014. Clin Rheumatol (2016) 0.75